Abstract
Nexplanon® is an etonogestrel implant with a long-acting contraceptive effect. Although
several studies underlined its safety profile, its implant can rarely lead to moderate
or severe adverse event. Here, we presented a case of delayed-type hypersensitivity
reaction against Nexplanon® that resolved after its removal.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to ContraceptionAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Nexplanon, a radiopaque etonogestrel implant in combination with a next-generation applicator: 3-year results of a noncomparative multicenter trial.Am J Obstet Gynecol. 2012; 207: 388.e1-388.e6
- One-year continuation of the etonogestrel contraceptive implant in women with postabortion or interval placement.Contraception. 2013; 88: 619-623
- Delayed type hypersensitivity: current theories with an historic perspective.Dermatol Online J. 1999; 5: 7
- An allergic reaction to Implanon placement and review of the literature.J Ark Med Soc. 2011; 108: 92
- Allergy to nexplanon®.J Fam Plann Reprod Health Care. 2012; 38: 272
Article info
Publication history
Published online: September 17, 2014
Accepted:
August 31,
2014
Received in revised form:
August 25,
2014
Received:
May 3,
2014
Footnotes
☆Conflicts of interest: None of the authors declare conflicts of interest.
☆☆No funding sources supported this investigation.
Identification
Copyright
© 2014 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
